Retatrutide goes further by: Reducing appetite Improving insulin sensitivity Increasing calorie burn Targeting visceral and metabolically active fat Supporting lean mass preservation This multi-mechanistic action is why retatrutide is being described as a next-generation metabolic therapy, rather than just a weight-loss drug
Avoid unregulated online sources that claim to offer retatrutide
And while its always best to get these nutrients from food, supplements can help fill in the gaps, especially when your appetite is tamped down
Read our Refund & Returns Policy
Weight loss typically continues, with clinical trials showing that semaglutide 2.4 mg (Wegovy) produces average weight loss of approximately 15% by week 68, while tirzepatide (Zepbound) has demonstrated weight loss of approximately 15-21% across different doses by week 72
The first trialTRIUMPH 1 is estimated to last until May 2026, and it aims to enrol 2300 patients [45]